| # of patients |
20 |
4 |
11 |
5 |
| Age at blood draw (Median, IQR) |
36.9 (26.5–43.8) |
29.0 (22.4–36.6) |
35.8 (26.3–40.7) |
46.5 (42.7–51.2) |
| # female |
9/20 |
0/4 |
6/11 |
3/5 |
| BMI (Median, IQR) |
25.6 (22.8–29.6) |
26.5 (25.6–28.1) |
24.7 (22.5–28.9) |
23.5 (22.7–31.4) |
| NHYA (Median, range) |
1.8 (1–2) |
2 |
2 |
2 |
| Number of surgeries (Median, range) |
2 (1–4) |
2 (1–3) |
2 (1–4) |
2 (1–3) |
| Age at complete repair (Median, IQR) |
5 (1.75–9.25) |
6 (1.75–18) |
5 (2–9.5) |
5 (1–6) |
| # prior palliative shunt |
7/20 |
1/4 |
3/11 |
3/5 |
| # transannular patch |
16/20 |
3/4 |
8/11 |
5/5 |
| # RV to PA conduit |
6/20 |
1/4 |
4/11 |
1/5 |
| # pulmonary valve replacement |
3/20 |
1/4 |
1/11 |
1/5 |
| # on diuretic |
3/20 |
1/4 |
1/11 |
1/5 |
| # on beta blocker |
7/20 |
1/4 |
3/11 |
3/5 |
| Na (mmol/L) (Median, IQR) |
139 (138–140) |
138 (137.5–141) |
139 (137.5–140.5) |
140 (139–141) |
| Cr (mg/dL) (Median, IQR) |
0.8 (0.71–0.85) |
0.75 (0.67–0.8) |
0.79 (0.7–0.85) |
0.86 (0.8–0.9) |
| AST (U/L) (Median, IQR) |
24 (20–32) |
24 (22–45) |
23 (15–32) |
30 (22–32) |
| ALT (U/L) (Median, IQR) |
33 (25–77) |
46 (40–72) |
26 (24–77) |
30 (29–52) |
| Alk Phos (U/L) (Median, IQR) |
76 (62–88) |
104 (88–110) |
71 (54–86) |
78 (62–79) |
| Total Bilirubin (mg/dL) (Median, IQR) |
0.6 (0.4–0.8) |
0.4 (0.3–0.5) |
0.6 (0.5–0.8) |
0.4 (0.4–1) |
